BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bioinformatics Software | QIAGEN Digital Insights - ECPv6.15.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bioinformatics Software | QIAGEN Digital Insights
X-ORIGINAL-URL:https://staging.digitalinsights.supremeclients.com
X-WR-CALDESC:Events for Bioinformatics Software | QIAGEN Digital Insights
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240514T130000
DTEND;TZID=America/New_York:20240514T143000
DTSTAMP:20260404T115722
CREATED:20240416T125942Z
LAST-MODIFIED:20241024T183033Z
UID:10000746-1715691600-1715697000@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN Biomedical Knowledge Base: data- and analytics-driven drug discovery
DESCRIPTION:Ingenuity pathway analysis (IPA) which is currently cited in tens of thousands of publications and used by large number of biopharmaceuticals is backed by QIAGEN Biomedical Knowledgebase. Accordingly\, Biomedical relationships knowledge has more or less become a requirement for innovative data- and analytics-driven drug discovery. It powers biomedical knowledge graph analysis\, artificial intelligence (AI)-driven target identification and many more applications. \nIn this 1hr webinar\, the speaker will introduce Biomedical Knowledgebase and how it allows its users to tackle applications that are not doable by Ingenuity Pathway Analysis graphical user interface or can be done faster and with more flexibility programmatically. The speaker will demonstrate queries such as \n• Quickly find the shortest connections between genes/proteins/metabolites of interest in the context of specific disease through queries\n• Systematically build a network given a short list genes/proteins/metabolites/chemicals\n• Recreate a drug mechanism of action \nNote: Per feedback of registrants\, we may edit above topics as we would like to cover what would be most relevant to you.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/qiagen-biomedical-knowledge-base-data-and-analytics-driven-drug-discovery-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1212_9_QDI_QDI_BKB_Original_61828_16x9_62947_Large-1200px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240513
DTEND;VALUE=DATE:20240516
DTSTAMP:20260404T115722
CREATED:20240418T145504Z
LAST-MODIFIED:20241024T183036Z
UID:10000752-1715558400-1715817599@staging.digitalinsights.supremeclients.com
SUMMARY:International Symposium of Variants 2024
DESCRIPTION:
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/international-symposium-of-variants-2024/
LOCATION:Porto\, Porto\, Portugal
CATEGORIES:Clinical,Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240507T130000
DTEND;TZID=America/New_York:20240507T150000
DTSTAMP:20260404T115722
CREATED:20240416T165254Z
LAST-MODIFIED:20241024T183033Z
UID:10000747-1715086800-1715094000@staging.digitalinsights.supremeclients.com
SUMMARY:New user training: Large dataset analysis and knowledge base queries using QIAGEN Ingenuity Pathway Analysis (IPA)
DESCRIPTION:Join us for a 120-minute training session for new users of QIAGEN IPA. \nIn this training\, you’ll learn how to:\n• Upload your dataset (RNA-seq\, scRNA-seq\, proteomics\, metabolomics and more) and perform interactive core/pathway analysis in IPA\n• Understand the different result types produced (pathways\, key regulators\, impact on biological functions/diseases and more)\n• Compare different experimental conditions (treatments\, time points\, single-cell clusters\, disease types and more) and identify similarities and contrasts\n• Generate a network even without a dataset or experimental design for hypothesis generation \nFor those with IPA license\,\nTo install IPA before or after this training\, please use below installer.\nhttps://qiagen.showpad.com/share/CBv30blCPKFDUYHRWtAvI
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/new-user-training-large-dataset-analysis-and-knowledge-base-queries-using-qiagen-ingenuity-pathway-analysis-ipa-10/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1032_8_QDI_IPAlandExplorer_Gi1170740969_16x9_Medium-720px_52991-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240502T130000
DTEND;TZID=America/New_York:20240502T143000
DTSTAMP:20260404T115722
CREATED:20240502T035308Z
LAST-MODIFIED:20241024T183038Z
UID:10000756-1714654800-1714660200@staging.digitalinsights.supremeclients.com
SUMMARY:Network construction and customization with QIAGEN Ingenuity Pathway Analysis
DESCRIPTION:Per attendees’ requests from a recent training\, we are hosting this in-depth training focused on effectively constructing a network\, with or without a dataset (RNA-seq\, proteomics\, etc.)\, and easily modifying it – all within Ingenuity Pathway Analysis. \nIn this interactive training\, attendees will learn how to: \n• Construct a network from scratch or open a network/pathway of interest from their analysis or the Ingenuity Knowledge Base\n• Effectively use tools present in the Build and Overlay menus to add molecules (genes/proteins\, chemicals\, metabolites)\, biological processes/diseases of their interest and more\n• Modify the network (e.g.\, to keep only a specific type of relationship like activation\, phosphorylation\, protein-protein binding and more)\n• Perform in silico prediction (e.g.\, if a drug\, siRNA or CRISPR were to reduce the activity of a gene/protein\, how will it impact the remaining genes/proteins/diseases in that network)\n• Export high-resolution graphics or tabular relationships and make the created network usable in future pathway analysis \nAdditional QIAGEN Digital Insights (QDI) scientists will be on the call to answer your questions and help with other concerns\, such as installing the software. \nTo learn more about IPA or request a trial: https://digitalinsights.qiagen.com/products-overview/discovery-insights-portfolio/analysis-and-visualization/qiagen-ipa/?cmpid=CM_QDI_DISC_052024webinars-network
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/network-construction-and-customization-with-qiagen-ingenuity-pathway-analysis-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1233_1_QDI_QDI_IPA_AOP_16x9_63871_Large-1200px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240430T130000
DTEND;TZID=America/New_York:20240430T143000
DTSTAMP:20260404T115722
CREATED:20240315T175627Z
LAST-MODIFIED:20241024T183029Z
UID:10000741-1714482000-1714487400@staging.digitalinsights.supremeclients.com
SUMMARY:IPA deep dive: miRNA investigation using QIAGEN Ingenuity Pathway Analysis (IPA)
DESCRIPTION:In this 90-minute training session\, you will learn how to identify target mRNAs for your miRNAs of interest and associate them with pathways\, diseases\, biological functions\, tissues and cell types. \nWe’ll cover topics such as:\n• How to analyze miRNA-seq datasets alone or both miRNA and corresponding mRNA datasets together\n• How to use QIAGEN IPA without a dataset\, using miRNA IDs\n• Introduction to databases and curated content specific to miRNA\n• How to effectively apply various filters and functionalities to identify biomarkers\, key targets and biological mechanisms \nTo learn more about IPA or request for a trial:\nhttps://digitalinsights.qiagen.com/products-overview/discovery-insights-portfolio/analysis-and-visualization/qiagen-ipa/?cmpid=CM_QDI_DISC_042024webinars-miRNA
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/ipa-deep-dive-mirna-investigation-using-qiagen-ingenuity-pathway-analysis-ipa/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9785_QDI_IPA_GI545875183_16x9_54188_Large-1200px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240423T130000
DTEND;TZID=America/New_York:20240423T143000
DTSTAMP:20260404T115722
CREATED:20240315T175216Z
LAST-MODIFIED:20241024T183029Z
UID:10000740-1713877200-1713882600@staging.digitalinsights.supremeclients.com
SUMMARY:DNA-seq analyses (whole genome\, whole exome\, panel) using QIAGEN CLC Genomics Workbench
DESCRIPTION:In this training\, we’ll go over how to easily perform DNA-seq analyses (for whole genome\, whole exome\, panel and similar) easily and effectively using QIAGEN CLC Genomics Workbench. \nTogether\, we’ll explore:\n• Read mapping\n• Variant calling (SNPs\, mutations\, Indels and more)\n• Annotations and filters\n• Genome Browser \nPlease bring any questions you may have\, and we will answer them during this training. To learn more about CLC Genomics Workbench or request for a trial:\nhttps://digitalinsights.qiagen.com/products-overview/discovery-insights-portfolio/analysis-and-visualization/qiagen-clc-workbench-premium/?cmpid=CM_QDI_DISC_042024webinars-DNAseq
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/dna-seq-analyses-whole-genome-whole-exome-panel-using-qiagen-clc-genomics-workbench/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1040_8_QDI_CLC_GWBv21_Gi470306612_16x9_Large-1200px_53596-768x432-1-1-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240422
DTEND;VALUE=DATE:20240424
DTSTAMP:20260404T115722
CREATED:20240418T150027Z
LAST-MODIFIED:20241024T183037Z
UID:10000754-1713744000-1713916799@staging.digitalinsights.supremeclients.com
SUMMARY:Swiss Biotech Day 2024
DESCRIPTION:
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/swiss-biotech-day-2024/
LOCATION:Basel\, Basel\, Switzerland
CATEGORIES:Discovery,Event
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240422
DTEND;VALUE=DATE:20240424
DTSTAMP:20260404T115722
CREATED:20240418T145144Z
LAST-MODIFIED:20241024T183036Z
UID:10000751-1713744000-1713916799@staging.digitalinsights.supremeclients.com
SUMMARY:Nordic Precision Medicine Forum 2024
DESCRIPTION:
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/nordic-precision-medicine-forum-2024/
LOCATION:Stockholm\, Stockholm\, Sweden
CATEGORIES:Clinical,Event
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240418
DTEND;VALUE=DATE:20240420
DTSTAMP:20260404T115722
CREATED:20240418T145841Z
LAST-MODIFIED:20241024T183037Z
UID:10000753-1713398400-1713571199@staging.digitalinsights.supremeclients.com
SUMMARY:Ai and Data in Pharma Healthcare Summit
DESCRIPTION:
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/ai-and-data-in-pharma-healthcare-summit/
LOCATION:Munich\, Munich\, Germany
CATEGORIES:Discovery,Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240416T130000
DTEND;TZID=America/New_York:20240416T140000
DTSTAMP:20260404T115722
CREATED:20240315T174929Z
LAST-MODIFIED:20241024T183028Z
UID:10000739-1713272400-1713276000@staging.digitalinsights.supremeclients.com
SUMMARY:Germline and Somatic Variant Investigation using COSMIC\, HGMD and QCI-IT
DESCRIPTION:The accurate identification and annotation of germline and somatic variants rely on the accuracy and depth of reference databases that contain information about the genetic variants\, any associated phenotype\, and their clinical implications. By combining COSMIC\, HGMD and QIAGEN QCI-IT\, scientists can annotate gene variants using the world’s most comprehensive and up-to-date curated scientific evidence and find biological connections in gene variants with manually curated scientific findings. The software and databases allow you to get valuable and reliable insights for your research project and speed up your discoveries related to disease-causing and disease-associated germline and somatic variants. \nIn this training\, you will:\n1. Learn about COSMIC\, the world’s largest\, most comprehensive\, expert-curated resource for somatic mutations in human cancers\, and how COSMIC can help you identify variants of interest for cancer research.\n2. Hear about the breadth and depth of HGMD (Human Gene Mutation Database) and how HGMD can aid in your search for disease-causing and disease-associated germline mutations.\n3. Explore the capabilities of QCI-IT\, which can help accelerate your discoveries from hereditary or tumor cohort analyses\, and find associations between gene variants and diseases from VCF files. \nTo learn more about the products or request for a trial: \nCOSMIC: https://digitalinsights.qiagen.com/products-overview/cosmic/?cmpid=CM_QDI_DISC_042024webinars \nHGMD: https://digitalinsights.qiagen.com/products-overview/clinical-insights-portfolio/human-gene-mutation-database/?cmpid=CM_QDI_DISC_042024webinars \nQCI-IT: https://digitalinsights.qiagen.com/products-overview/discovery-insights-portfolio/qci-interpret-translational/?cmpid=CM_QDI_DISC_042024webinars
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/germline-and-somatic-variant-investigation-using-cosmic-hgmd-and-qci-it/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Clinical,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1326_4_QDI_QDI_gene_variants_0086-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240411T130000
DTEND;TZID=America/New_York:20240411T140000
DTSTAMP:20260404T115722
CREATED:20240405T130707Z
LAST-MODIFIED:20241024T183032Z
UID:10000745-1712840400-1712844000@staging.digitalinsights.supremeclients.com
SUMMARY:Gene set enrichment\, target validation and more using high quality biomedical literature findings
DESCRIPTION:This 60-minute session will teach you how to effectively use a relationship database for various applications. QIAGEN Biomedical Knowledge Base (Biomedical KB)\, a database containing high-quality relationship literature findings\, the same database backing Ingenuity Pathway Analysis/IPA) will be used\, but learnings can also be applied to similar databases. \nThe following points will be discussed: \n• Gene set enrichment analysis using Biomedical KB\n• Target validation through Biomedical KB findings\n• Potential other use cases\, queries and applications requested by registrants
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/gene-set-enrichment-target-validation-and-more-using-high-quality-biomedical-literature-findings/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1212_9_QDI_QDI_BKB_Original_61828_16x9_62947_Large-1200px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240409T130000
DTEND;TZID=America/New_York:20240409T140000
DTSTAMP:20260404T115722
CREATED:20240315T174306Z
LAST-MODIFIED:20241024T183028Z
UID:10000738-1712667600-1712671200@staging.digitalinsights.supremeclients.com
SUMMARY:Integrating deeply curated omics data with APIs for biomarkers and drug target investigation
DESCRIPTION:This webinar is for data scientists and bioinformaticians who need extensive high-quality omics data to target discovery efforts. Learn how to programmatically discover\, retrieve\, filter\, aggregate and analyze omics (RNA-seq\, scRNA-seq\, microarray\, proteomics etc.) data from QIAGEN’s comprehensive repository of deeply curated multi-omics data. Attendees will learn how to leverage extensive metadata to find and combine datasets of interest\, find and test signatures\, and perform custom analyses to reveal disease-related patterns. \nJoin us to learn how QIAGEN OmicSoft Lands API can revolutionize your data analysis workflows and help you make more informed decisions. Topics to be covered:\n• Search for gene signatures to find relevant datasets through Gene Set Analysis\n• Identify the correlation of results\n• Find multiple datasets with the same metadata (metadata refers to cell type\, tissue\, disease\, drug treatment etc.\, associated with public data)\n• Perform meta-analysis for novel discoveries\n• Test cell specificity with custom aggregation
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/integrating-deeply-curated-omics-data-with-apis-for-biomarkers-and-drug-target-investigation-3/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9308_BIOX_OmicSoft_Gi576919878_V2_Large-1200px_47746-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240408
DTEND;VALUE=DATE:20240411
DTSTAMP:20260404T115722
CREATED:20240327T145856Z
LAST-MODIFIED:20241024T183032Z
UID:10000744-1712534400-1712793599@staging.digitalinsights.supremeclients.com
SUMMARY:Human Genome Meeting 2024
DESCRIPTION:This year at the Human Genome Meeting (HGM)\, QIAGEN will be showcasing our Sample to Insight solutions for whole genome\, exome\, and large panel sequencing for oncology and inherited disease applications. Learn more about our products and solutions and receive complimentary demos of our bioinformatic software and databases. Our experts will be available to chat with you and answer any questions you may have. We look forward to seeing you at HGM 2024. \n\n\nDon't miss the QIAGEN symposium! \n\n\n\n\nJoin Dr. Michela Bulfoni of the Istituto di Anatomia Patologica Azienda Sanitaria Universitaria Friuli Centrale\, Udine\, as she discusses how her lab is using Sample to Insight solutions from QIAGEN\, including two custom NGS panels\, CLC Genomics Workbench\, and QCI Interpret\, to perform tumor molecular profiling as a routine part of clinical diagnostics.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/human-genome-meeting-2024/
LOCATION:Rome\, Italy\, Rome\, Italy
CATEGORIES:Clinical,Event
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1377_7_CC_GEN_Rome_pexels532263.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240404T130000
DTEND;TZID=America/New_York:20240404T150000
DTSTAMP:20260404T115722
CREATED:20240326T050151Z
LAST-MODIFIED:20241024T183031Z
UID:10000742-1712235600-1712242800@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN Ingenuity Pathway Analysis (IPA) new user training
DESCRIPTION:Large dataset analysis and exploring the knowledge base using QIAGEN Ingenuity Pathway Analysis (IPA) \nJoin us for a 120-minute training session for new users of QIAGEN IPA. \nIn this training\, you’ll learn how to: \n• Upload your dataset (RNA-seq\, scRNA-seq\, proteomics\, metabolomics and more) and perform interactive core/pathway analysis in IPA\n• Understand the different result types produced (pathways\, key regulators\, impact on biological functions/diseases and more)\n• Compare different experimental conditions (treatments\, time points\, single-cell clusters\, disease types and more) and identify similarities and contrasts\n• Generate a network even without a dataset or experimental design for hypothesis generation \nFor those with IPA licenses: download the installer from the link below to install IPA before or after the training.\nhttps://qiagen.showpad.com/share/CBv30blCPKFDUYHRWtAvI \nTo learn more about IPA or request a trial: https://digitalinsights.qiagen.com/products-overview/discovery-insights-portfolio/analysis-and-visualization/qiagen-ipa/?cmpid=CM_QDI_DISC_042024webinars-NUT
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/qiagen-ingenuity-pathway-analysis-ipa-new-user-training/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9978_QDI_IPA_Gi609807396_16x9_Medium-720px_50570.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240404T130000
DTEND;TZID=America/New_York:20240404T140000
DTSTAMP:20260404T115722
CREATED:20240307T033431Z
LAST-MODIFIED:20241024T183027Z
UID:10000737-1712235600-1712239200@staging.digitalinsights.supremeclients.com
SUMMARY:How to scale-up comprehensive genomic profiling and deliver confident variant interpretations with QCI Interpret for Oncology
DESCRIPTION:In this webinar\, attendees will learn how QCI Interpret for Oncology enables you to: \n\nNavigate from VCF to final report with speed\, precision\, and confidence;\nEasily issue report addendums without the need for re-running a VCF;\nStreamline structural variant filtering based on user-set thresholds and hence reduce the time and effort needed to eliminate noise and identify truly relevant variants for reporting;\nUtilize built-in AI capabilities to identify all the literature\, case reports\, drug therapies\, and clinical studies relevant to a patient’s tumor type with just one click.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/how-to-scale-up-comprehensive-genomic-profiling-and-deliver-confident-variant-interpretations-with-qci-interpret-for-oncology-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Clinical,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1314_3_QDI_QCI_SampletoInsight_Oncology_GI1388388119.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240328T130000
DTEND;TZID=America/New_York:20240328T143000
DTSTAMP:20260404T115722
CREATED:20240219T134411Z
LAST-MODIFIED:20241024T183026Z
UID:10000734-1711630800-1711636200@staging.digitalinsights.supremeclients.com
SUMMARY:Multi-omics (metabolomics\, proteomics\, transcriptomics) analysis using QIAGEN Ingenuity Pathway Analysis
DESCRIPTION:This 90-minute training session will show you how QIAGEN Ingenuity Pathway Analysis (IPA) visualizes molecular intricacies and variations at the transcriptome\, proteome and metabolome levels. Through a series of brief technical vignettes\, you will learn how to: • Generate associations among molecular signatures obtained by integrating multi-omics data  • Extract mechanisms from multi-omics data for precision medicine  • Disease stratification based on multi-omics profiles  • Map disease networks among targets and indications 
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/multi-omics-metabolomics-proteomics-transcriptomics-analysis-using-qiagen-ingenuity-pathway-analysis-3-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1062_0_IPA_Challenger_029613_16x9_Large-1200px_54798.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240326T130000
DTEND;TZID=America/New_York:20240326T143000
DTSTAMP:20260404T115722
CREATED:20240219T134033Z
LAST-MODIFIED:20241024T183026Z
UID:10000733-1711458000-1711463400@staging.digitalinsights.supremeclients.com
SUMMARY:Single-Cell RNA-Seq\, Cell Hashing\, and Spatial Transcriptomics
DESCRIPTION:A slide illustrating some of the many result types/graphics you will be able to generate after this training. https://qiagen.showpad.com/share/jYTCDPNfz1SdIMPQPSPYS  Description: In this training\, you will learn how to analyze and interpret your own single-cell RNA-seq data using QIAGEN CLC Genomics Workbench\, starting with either FASTQ or matrix files.  Using CLC Genomics Workbench\, you will learn how to perform secondary analysis on your single-cell RNA-seq data. Specifically\, you will learn how to: • Import your raw FASTQ or processed cell-matrix files • Use pre-configured but customizable pipelines/workflows for single-cell RNA-seq data • Generate high-resolution visuals and other files from your analysis for publications and biopharmaceutical discoveries o Dimension reduction (UMAP\, t-SNE) plots o Differential expression tables for clusters\, cell types\, or a combination of both o Heat map o Dot plots o Violin plots • Learn how to use “Create Cell Annotations from Hashtags” for cell hashing\, as with CITE-seq • Dive into spatial transcriptomic analysis\, the latest feature in the single-cell RNA-seq module 
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/single-cell-rna-seq-cell-hashing-and-spatial-transcriptomics-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1064_6_OmicSoft-Single-Cell-Lands_QDI7303_16x9-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240326T110000
DTEND;TZID=America/New_York:20240326T120000
DTSTAMP:20260404T115722
CREATED:20240207T214719Z
LAST-MODIFIED:20241024T183021Z
UID:10000728-1711450800-1711454400@staging.digitalinsights.supremeclients.com
SUMMARY:Agilent Alissa to QCI Interpret: How can your lab reduce the stress and complexity of transitioning to a new clinical informatics platform?
DESCRIPTION:In 2023\, Agilent announced the discontinuation of their Alissa Interpret clinical informatics platform by the end of 2024. As a result\, many of their current customers need to transition to a new variant interpretation and reporting software within a tight timeframe. However\, when evaluating new interpretation solutions\, clinical labs must consider a variety of factors\, including: \n\nContent quality for clinical reporting\nFlexibility to adapt current workflows to a new platform\nRetaining historical content and comments\nEase of personnel training\n\nIn this webinar\, learn about QCI Interpret\, a panel- and sequencer-agnostic clinical informatics platform for NGS variant interpretation and reporting of germline and somatic tests. Our experts will address the concerns of current Agilent Alissa users and discuss what sets QCI Interpret apart from other interpretation solutions. In addition\, we will show you how seamless it is to transition your historical data and comments into QCI Interpret\, as well as provide a live demonstration of the industry-leading and reliable software that has been used to analyze and interpret more than 3.5 million patient test cases worldwide. \n 
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/agilent-alissa-to-qci-interpret-how-can-your-lab-reduce-the-stress-and-complexity-of-transitioning-to-a-new-clinical-informatics-platform/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Clinical,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/QPRO-6432_WEBINAR_QCI_Conversion_March_16x9.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240321T110000
DTEND;TZID=UTC:20240321T120000
DTSTAMP:20260404T115722
CREATED:20240222T171620Z
LAST-MODIFIED:20241024T183027Z
UID:10000735-1711018800-1711022400@staging.digitalinsights.supremeclients.com
SUMMARY:Expert Roundtable: Advances in Genomic Testing for Rare Disease Diagnostics
DESCRIPTION:Over the past decade\, whole-exome and whole-genome sequencing have transformed the diagnosis of patients with suspected rare genetic diseases. However\, despite recent advancements\, a large number of patients with rare genetic diseases remains undiagnosed for years because they have limited access to comprehensive genomic testing. \nIn this virtual roundtable of leading rare disease experts\, panelists will discuss: \n\nThe state of clinical genomic testing for rare disease at their institutions.\nHow recent advances in sequencing technology and data analysis\, including artificial intelligence (AI)\, are increasing diagnostic rate.\nHow barriers to patient access to testing can be removed to improve the care of all people living with rare genetic diseases.\n\n  \nPanelists:  \nDanny E. Miller\, MD\, PhD\nAssistant Professor\, Department of Pediatrics\, Division of Genetic Medicine\, University of Washington \nVaidehi Jobanputra\, PhD\, FACMG\nAssociate Professor of Pathology and Cell Biology\, Columbia University Medical Center \nGilad D. Evrony\, MD\, PhD\nAssistant Professor\, Departments of Pediatrics and Neuroscience and Physiology\, NYU School of Medicine\n\n\nMalte Spielmann\, MD\, PhD\nProfessor of Human Genetics\, University Hospital Schleswig-Holstein\, Germany
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/expert-roundtable-advances-in-genomic-testing-for-rare-disease-diagnostics/
CATEGORIES:Clinical,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/QPRO-6353_WEBINAR_QCI_Alissa_March_16x9.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240314T130000
DTEND;TZID=America/New_York:20240314T143000
DTSTAMP:20260404T115722
CREATED:20240219T133254Z
LAST-MODIFIED:20241024T183023Z
UID:10000732-1710421200-1710426600@staging.digitalinsights.supremeclients.com
SUMMARY:Using ATCC cell line data for cell line selection\, validation and other applications
DESCRIPTION:Cancer cell line models have been a cornerstone of cancer research for decades. Profiling cancer cell lines can be a powerful tool to identify gene alterations or cancer-related pathways and aid in discovering putative drug targets. In this webinar\, we'll use QIAGEN OmicSoft Lands and QIAGEN Ingenuity Pathway Analysis (IPA) to help you select cell lines and translate insights from your cell line experiments for drug target discovery. \nDuring this 90-minute discussion\, we'll explore how you can use these software tools to:  \n• Select appropriate cancer cell lines for a variety of applications such as drug discovery\, precision disease modeling\, understanding gene function in cancer\, immune-oncology research\, and more\n• Examine various 'omics data for genes of interest for expression\, mutation\, hotspots\, and gene dependency data\n• Generate networks for hypotheses and test them in silico to improve the translation of insights derived from cell line models to drug target identification\n• Integrate analyses of public 'omics data and drug response phenotypes using cell line model systems by exploring data from the Library of Integrated Network-Based Cellular Signatures (LINCS)\n• Prioritize drug targets and profile phenotypic/downstream effects of drug action by overlaying public data on user-generated networks \nOur system uses millions of curated literature findings from the QIAGEN Knowledge Base and the OmicSoft digital warehouse. This discussion is intended for both those familiar with QIAGEN IPA and newcomers interested in learning more. 
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/using-atcc-cell-line-data-for-cell-line-selection-validation-and-other-applications/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1276_1_QDI_QDI_ATCC_Generic.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240307T110000
DTEND;TZID=America/New_York:20240307T120000
DTSTAMP:20260404T115722
CREATED:20240207T185132Z
LAST-MODIFIED:20241024T183019Z
UID:10000726-1709809200-1709812800@staging.digitalinsights.supremeclients.com
SUMMARY:Using COSMIC to predict\, identify\, and avoid mutational consequences of cancer therapies during early drug development and in patients
DESCRIPTION:Whether your lab is researching and developing targeted cancer therapies or you are analyzing and interpreting diagnostic tests at the point-of-care\, a critical part of your workflow is understanding the structural and functional impact of cancer-related mutations. \nThe Catalogue Of Somatic Mutations In Cancer (COSMIC) is an expert-curated database encompassing a wide variety of somatic mutation mechanisms causing human cancer. Containing more than 24 million somatic variants with detailed information on mutation distribution\, effects\, and signatures\, COSMIC helps users better predict the cancer-driving effects of mutations and identify available drugs that target specific variants. COSMIC continues to expand its utility with continuous updates to its Mutational Signatures\, the Cancer Mutation Census\, and Mutation Actionability in Precision Oncology products. \nTo illustrate key applications of these features\, this webinar will focus on how COSMIC can be used to avoid mutational consequences in cancer drug development and to detect mutational consequences of therapies in clinical diagnostics. \nThrough these clinical and discovery use cases\, attendees will: \n\nLearn how to use COSMIC to identify and prioritize coding and non-coding mutational hotspots\nUnderstand how COSMIC helps determine actionability of clinically approved homologous recombination deficiency signatures\nExplore future uses of non-coding and signature-based COSMIC content for drug development and potential clinical diagnostic applications
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/using-cosmic-to-predict-identify-and-avoid-mutational-consequences-of-cancer-therapies-during-early-drug-development-and-in-patients-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Clinical,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/QPRO-6076_WEBINAR_QCI_COSMIC_DrugDevelopment_16x9-002.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240306T130000
DTEND;TZID=America/New_York:20240306T150000
DTSTAMP:20260404T115722
CREATED:20240219T132838Z
LAST-MODIFIED:20241024T183023Z
UID:10000731-1709730000-1709737200@staging.digitalinsights.supremeclients.com
SUMMARY:New user training: Large dataset analysis and knowledge base queries using QIAGEN Ingenuity Pathway Analysis (IPA)
DESCRIPTION:Join us for a 120-minute training session for new users of QIAGEN IPA. \nIn this training\, you’ll learn how to:  \n\nUpload your dataset (RNA-seq\, scRNA-seq\, proteomics\, metabolomics and more) and perform interactive core/pathway analysis in IPA\nUnderstand the different result types produced (pathways\, key regulators\, impact on biological functions/diseases and more)\nCompare different experimental conditions (treatments\, time points\, single-cell clusters\, disease types and more) and identify similarities and contrasts\nGenerate a network even without a dataset or experimental design for hypothesis generation\nFor those with an IPA license\,\nTo install IPA before or after this training\, please use the below installer.\nhttps://qiagen.showpad.com/share/CBv30blCPKFDUYHRWtAvI 
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/new-user-training-large-dataset-analysis-and-knowledge-base-queries-using-qiagen-ingenuity-pathway-analysis-ipa-9/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9978_QDI_IPA_Gi609807396_16x9_Medium-720px_50570.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240229T130000
DTEND;TZID=America/New_York:20240229T143000
DTSTAMP:20260404T115722
CREATED:20240229T104537Z
LAST-MODIFIED:20241024T183027Z
UID:10000736-1709211600-1709217000@staging.digitalinsights.supremeclients.com
SUMMARY:Biomarker discovery\, target validation\, and variant identification using QIAGEN OmicSoft DiseaseLand\, Human Gene Mutation Database\, and Ingenuity Pathway Analysis
DESCRIPTION:In this webinar\, users will learn how to leverage solutions from QIAGEN Digital Insights to discover biomarkers\, validate targets\, and identify variants. Specifically\, users will learn:\n1. How to locate public studies of interest using OmicSoft DiseaseLand.\n2. Investigate the expression of genes of interest across different treatments\, disease states\, etc.\n3. Identify variants of interest for candidate biomarkers and targets using the Human Gene Mutation Database.\n4. Leveraging the QIAGEN Knowledgebase in Ingenuity Pathway Analysis to explore and extend findings from OmicSoft DiseaseLand and Human Gene Mutation Database.\n5. Learn about additional methods to access data from OmicSoft\, Human Gene Mutation Database\, and Ingenuity Pathway Analysis for data scientists.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/biomarker-discovery-target-validation-and-variant-identification-using-qiagen-omicsoft-diseaseland-human-gene-mutation-database-and-ingenuity-pathway-analysis/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/ILLU_1851_QDI_QDI_biomedical_knowledge_base-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240227T130000
DTEND;TZID=America/New_York:20240227T143000
DTSTAMP:20260404T115722
CREATED:20240111T165729Z
LAST-MODIFIED:20241024T183004Z
UID:10000723-1709038800-1709044200@staging.digitalinsights.supremeclients.com
SUMMARY:Public single-cell RNA-seq data investigation using QIAGEN Omicsoft and Ingenuity Pathway Analysis
DESCRIPTION:Single-cell RNA-sequencing (scRNA-seq) is widely used to investigate tissue heterogeneity\, identify novel cell types\, study pathogenic mechanisms\, develop targeted therapy (including immunotherapy) and more. Accordingly\, a tremendous amount of scRNA-seq data has been deposited to public domains like GEO.  In this training\, you will learn how to  · Locate public single-cell studies of interest using QIAGEN Omicsoft Single-Cell Lands  · Study different cell types by dimension reduction plots (for example\, t-SNE\, UMAP)  · Investigate expression of genes of interest across different cell types (Violin plots\, overlay expression on cluster)  · Identify key pathways and regulators from scRNA-seq data using QIAGEN Ingenuity Pathway Analysis (IPA) 
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/public-single-cell-rna-seq-data-investigation-using-qiagen-omicsoft-and-ingenuity-pathway-analysis-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1064_1_OmicSoft-Single-Cell-Lands_029541_Large-1200px_54944.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240221T090000
DTEND;TZID=America/New_York:20240221T100000
DTSTAMP:20260404T115722
CREATED:20240207T213516Z
LAST-MODIFIED:20241024T183019Z
UID:10000727-1708506000-1708509600@staging.digitalinsights.supremeclients.com
SUMMARY:How biopharmaceutical companies can leverage expert-curated knowledge from Wellcome Sanger Institute and QIAGEN to accelerate cancer drug discovery and development
DESCRIPTION:The cancer drug discovery landscape is shifting. While research continues to grow in cost and complexity\, the pace of development has never been faster. Biopharmaceutical companies can’t afford to waste time and resources pursuing ineffective or unsafe ideas. \nIn this talk\, our experts discuss how biopharmaceutical companies can leverage key genomic\, biomedical\, and clinical trial databases to improve and accelerate cancer drug discovery while avoiding potential pitfalls. Through a series of use cases\, attendees will learn about expert-curated knowledge from the Wellcome Sanger Institute and QIAGEN\, and how to use these resources to better predict cancer-driving effects of mutations\, identify available drugs that target specific variants\, and accelerate indication expansion and repurposing of existing cancer therapies. \nLearning objectives: \n1. Examine use-cases of how to leverage expert-curated databases across multiple phases of cancer drug development. \n2. Discover key applications of these databases\, including determining the function\, frequency\, and actionability of specific mutations. \n3. Discuss potential pitfalls and clinical consequences\, and how to avoid them early with data-driven drug target and biomarker qualification.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/how-biopharmaceutical-companies-can-leverage-expert-curated-knowledge-from-wellcome-sanger-institute-and-qiagen-to-accelerate-cancer-drug-discovery-and-development/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1366_2_QDI_QCI_HSMDvsCOSMIC_Biopharmam.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240220T130000
DTEND;TZID=America/New_York:20240220T143000
DTSTAMP:20260404T115722
CREATED:20240111T165213Z
LAST-MODIFIED:20241024T183004Z
UID:10000722-1708434000-1708439400@staging.digitalinsights.supremeclients.com
SUMMARY:Mining curated knowledge graphs and validating with experimental datasets to accelerate your drug target discovery
DESCRIPTION:In an era of near-limitless public experimental data but little standardization\, meaningful insights are lost to noise. Large collections of quality experimental data are essential for big-picture discoveries that stand up to scrutiny. \nIn this webinar\, you will learn how to feed your drug discovery programs by integrating connections mined from QIAGEN Biomedical Knowledge Base with deeply curated disease datasets from QIAGEN OmicSoft Lands. \nCombining unified 'omics datasets with contextual relationship evidence from our knowledge graph\, we will address complex questions such as:   \n\n Which genes aren't expressed in normal tissue\, yet are expressed in diseases of interest\, based on experimental evidence?\n Which of these proteins are cell surface proteins\, with evidence for extracellular localization?\n How are these proteins related directly or indirectly to disease pathways\, and can these be connected to known drug targets?\n Can we identify correlated biomarkers\, mutation targets\, clinical factors or other means of cohort selection?
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/mining-curated-knowledge-graphs-and-validating-with-experimental-datasets-to-accelerate-your-drug-target-discovery/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240215T130000
DTEND;TZID=America/New_York:20240215T143000
DTSTAMP:20260404T115722
CREATED:20240215T173235Z
LAST-MODIFIED:20241024T183022Z
UID:10000729-1708002000-1708007400@staging.digitalinsights.supremeclients.com
SUMMARY:ATCC cell line data utilization for cell line selection\, validation and other applications
DESCRIPTION:Cancer cell line models have been a cornerstone of cancer research for decades. Profiling cancer cell lines can be a powerful tool to identify gene alterations or cancer-related pathways and aid in discovering putative drug targets. In this webinar\, we'll use QIAGEN OmicSoft Lands and QIAGEN Ingenuity Pathway Analysis (IPA) to help you select cell lines and translate insights from your cell line experiments for drug target discovery. \nDuring this 90-minute discussion\, we'll explore how you can use these software tools to:\n• Select appropriate cancer cell lines for a variety of applications such as drug discovery\, precision disease modeling\, understanding gene function in cancer\, immune-oncology research and more\n• Examine various 'omics data for genes of interest for expression\, mutation\, hotspots and gene dependency data\n• Generate networks for hypotheses and test them in silico to improve the translation of insights derived from cell line models to the drug target identification\n• Integrate analyses of public 'omics data and drug response phenotypes using cell line model systems by exploring data from the Library of Integrated Network-Based Cellular Signatures (LINCS)\n• Prioritize drug targets and profile phenotypic/downstream effects of drug action by overlaying public data on user-generated networks \nOur system uses millions of curated literature findings from QIAGEN Knowledge Base and the OmicSoft digital warehouse. This discussion is intended for both those familiar with QIAGEN IPA and newcomers interested in learning more.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/atcc-cell-line-data-utilization-for-cell-line-selection-validation-and-other-applications/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1276_1_QDI_QDI_ATCC_Generic.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240215T080000
DTEND;TZID=UTC:20240215T170000
DTSTAMP:20260404T115722
CREATED:20260404T115722Z
LAST-MODIFIED:20241024T183022Z
UID:10000730-1707984000-1708016400@staging.digitalinsights.supremeclients.com
SUMMARY:Single Cell RNA-Seq\, Cell Hashing\, and Spatial Transcriptomics
DESCRIPTION:In this training\, you will learn how to analyze and interpret your own single-cell RNA-seq data using QIAGEN CLC Genomics Workbench starting with either FASTQ or matrix files. \nUsing CLC Genomics Workbench\, you will learn how to perform secondary analysis on your single-cell RNA-seq data. Specifically\, you will learn how to:\n• Import your raw FASTQ or processed cell-matrix files.\n• Use pre-configured but customizable pipelines/workflows for single-cell RNA-seq data.\n• Generate high-resolution visuals and other files from your analysis for publications and biopharmaceutical discoveries.\no Dimension reduction (UMAP\, t-SNE) plots\no Differential expression table for clusters\, cell types\, or a combination of both\no Heat map\no Dot plots\no Violin plots\n• Learn how to use “Create Cell Annotations from Hashtags” for cell hashing (i.e.\, CITE-seq).\n• Dive into spatial transcriptomic analysis\, the latest feature in the single cell RNA-seq module.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/single-cell-rna-seq-cell-hashing-and-spatial-transcriptomics/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20240214T160000
DTEND;TZID=Europe/Paris:20240214T170000
DTSTAMP:20260404T115722
CREATED:20240111T164643Z
LAST-MODIFIED:20241024T183003Z
UID:10000721-1707926400-1707930000@staging.digitalinsights.supremeclients.com
SUMMARY:Introduction to Analysis Match in IPA - Compare your gene and protein expression data to over 100.000 published experimental data
DESCRIPTION:With all the expression datasets that are available to the public\, wouldn’t it be great to compare them to your own expression data\, so you could get a better understanding of the underlying biology of your data? \nWith QIAGEN IPA Analysis Match\, you can compare your expression data with well over 100\,000 publicly available datasets that have been processed and analyzed in IPA\, as well as all the IPA analyses that you have performed to date. \nIn this webinar\, we will cover how Analysis Match works and demonstrate this feature with a live demonstration. Feel free to follow along with your analysis and ask questions along the way!
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/introduction-to-analysis-match-in-ipa-compare-your-gene-and-protein-expression-data-to-over-100-000-published-experimental-data-2-2/
LOCATION:Virtual - EMEA - CET
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1233_1_QDI_QDI_IPA_AOP_16x9_63871_Large-1200px-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240214T100000
DTEND;TZID=America/New_York:20240214T110000
DTSTAMP:20260404T115722
CREATED:20240111T164231Z
LAST-MODIFIED:20241024T183002Z
UID:10000720-1707904800-1707908400@staging.digitalinsights.supremeclients.com
SUMMARY:Introduction to Analysis Match in IPA - Compare your gene and protein expression data to over 100.000 published experimental data
DESCRIPTION:With all the expression datasets that are available to the public\, wouldn’t it be great to compare them to your own expression data\, so you could get a better understanding of the underlying biology of your data? \nWith QIAGEN IPA Analysis Match\, you can compare your expression data with well over 100\,000 publicly available datasets that have been processed and analyzed in IPA\, as well as all the IPA analyses that you have performed to date. \nIn this webinar\, we will cover how Analysis Match works and demonstrate this feature with a live demonstration. Feel free to follow along with your analysis and ask questions along the way!
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/introduction-to-analysis-match-in-ipa-compare-your-gene-and-protein-expression-data-to-over-100-000-published-experimental-data-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1233_1_QDI_QDI_IPA_AOP_16x9_63871_Large-1200px-2.jpg
END:VEVENT
END:VCALENDAR